Investor Presentation Full Year 2017

Investor Presentation Full year 2017 Slide 96 Novo Nordisk maintains leadership within growth hormone market Development in global growth hormone market DKK billion 20 MAT volume kg CAGR volume¹: 7.5% CAGR value DKK¹: 0.0% Growth hormone volume market share Novo Nordisk Eli Lilly Pfizer Merck Kgaa Sandoz 15 10 5 0 Nov 2012 MAT value DKK kg 100 35% 30% 80 25% 60 20% 40 15% 10% 20 5% 0 0% Nov 2017 Nov 2012 1 CAGR for 5-year period Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 volume figures and value (DKK) figures changing diabetes® Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 volume figures 23% Nov 2017 novo nordisk

View entire presentation